Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences New Applications of NGS and PCR

Nazneen Rahman's Biography



Nazneen Rahman, Head of the Division of Genetics and Epidemiology, Institute of Cancer Research

Nazneen Rahman is Professor of Human Genetics at the Institute of Cancer Research (ICR) and Head of Division of Genetics & Epidemiology. She is also a Consultant Clinical Geneticist and Head of Cancer Genetics at The Royal Marsden.
Her research work has been directed towards the mapping and identification of human disease genes with her primary areas of research being breast cancer and childhood cancer susceptibility. She has identified 4 breast cancer predisposition genes (CHEK2, BRIP1, ATM, PALB2), an ovarian cancer predisposition gene (RAD51D) and three childhood cancer predisposition genes (BUB1B, PALB2, CEP57). She also has a strong commitment to translation of research findings, using gene identification data to clarify the prevalence and risks of mutations and to produce diagnostic and management guidance for rare cancer-associated conditions. She is currently leading a translational research programme which aims to introduce germline genetic testing into mainstream oncology services.

Nazneen Rahman Image

Using Next-generation Sequencing to Bring Routine Genetic Testing into Cancer Medicine

Wednesday, 16 October 2013 at 09:00

Add to Calendar ▼2013-10-16 09:00:002013-10-16 10:00:00Europe/LondonUsing Next-generation Sequencing to Bring Routine Genetic Testing into Cancer MedicineSELECTBIOenquiries@selectbiosciences.com

Next-generation sequencing offers the potential to revolutionise clinical diagnostics. This is particularly true in cancer; nearly 100 cancer predisposition genes with clinical utility are recognised, but clinical testing for the majority is not available or is very restricted. The Mainstreaming Cancer Genetics Programme (www.mcgprogramme.com) is seeking to address this, and a primary projective is the development of an NGS panel that can consistently and robustly identify genetic variants of relevance to cancer.


Add to Calendar ▼2013-10-16 00:00:002013-10-17 00:00:00Europe/LondonNew Applications of NGS and PCRSELECTBIOenquiries@selectbiosciences.com